These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14598304)

  • 1. Nonopioid receptor-mediated effects of U-50,488H on [Ca(2+)]i and extracellular dopamine in PC12 cells.
    Chudapongse N; Kim SY; Sasaki K; Kramer RE; Ho IK
    J Neurosci Res; 2003 Nov; 74(4):598-604. PubMed ID: 14598304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific effects of the selective kappa-opioid receptor agonist U-50,488H on dopamine uptake and release in PC12 cells.
    Chudapongse N; Kim SY; Kramer RE; Ho IK
    J Pharmacol Sci; 2003 Nov; 93(3):372-5. PubMed ID: 14646257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
    Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
    Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
    Raffa RB; Baron DA; Tallarida RJ
    Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
    Ukai M; Suzuki M; Mamiya T
    J Neural Transm (Vienna); 2002 Sep; 109(9):1221-5. PubMed ID: 12203050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Durham RA; Johnson JD; Moore KE; Lookingland KJ
    Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats.
    Mori T; Yoshizawa K; Ueno T; Nishiwaki M; Shimizu N; Shibasaki M; Narita M; Suzuki T
    Behav Pharmacol; 2013 Aug; 24(4):275-81. PubMed ID: 23838963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
    Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase C inhibitors attenuate arrhythmias induced by kappa-receptor stimulation in the isolated rat heart.
    Bian JS; Zhang WM; Xia Q; Wong TM
    J Mol Cell Cardiol; 1998 Oct; 30(10):2103-10. PubMed ID: 9799662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers.
    Pruhs RJ; Peña RT; Quock RM
    Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
    Cui CL; Wu LZ; Han JS
    Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Funada M; Suzuki T; Narita M; Misawa M; Nagase H
    Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
    Chen BP; Fan FY; Mao HJ; Xia Q
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):64-70. PubMed ID: 21186583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
    J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration.
    Doyon WM; Howard EC; Shippenberg TS; Gonzales RA
    Neuropharmacology; 2006 Sep; 51(3):487-96. PubMed ID: 16781738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
    Nazarian A; Krall CM; Osburn JR; McDougall SA
    Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety.
    Marco EM; Llorente R; Pérez-Alvarez L; Moreno E; Guaza C; Viveros MP
    Behav Brain Res; 2005 Sep; 163(2):212-8. PubMed ID: 15979169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.